| Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Y Iwai, M Ishida, Y Tanaka, T Okazaki, T Honjo, N Minato Proceedings of the National Academy of Sciences 99 (19), 12293-12297, 2002 | 3817 | 2002 |
| Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice H Nishimura, T Okazaki, Y Tanaka, K Nakatani, M Hara, A Matsumori, ... Science 291 (5502), 319-322, 2001 | 2374 | 2001 |
| Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer J Hamanishi, M Mandai, M Iwasaki, T Okazaki, Y Tanaka, K Yamaguchi, ... Proceedings of the National Academy of Sciences 104 (9), 3360-3365, 2007 | 1895 | 2007 |
| Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention Y Wu, Y Ding, Y Tanaka, W Zhang International journal of medical sciences 11 (11), 1185, 2014 | 1813 | 2014 |
| Natural and synthetic non-peptide antigens recognized by human γδ T cells Y Tanaka, CT Morita, Y Tanaka, E Nieves, MB Brenner, BR Bloom Nature 375 (6527), 155-158, 1995 | 1316 | 1995 |
| Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice T Okazaki, Y Tanaka, R Nishio, T Mitsuiye, A Mizoguchi, J Wang, M Ishida, ... Nature medicine 9 (12), 1477-1483, 2003 | 813 | 2003 |
| Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells CT Morita, EM Beckman, JF Bukowski, Y Tanaka, H Band, BR Bloom, ... Immunity 3 (4), 495-507, 1995 | 649 | 1995 |
| The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors DY Lin, Y Tanaka, M Iwasaki, AG Gittis, HP Su, B Mikami, T Okazaki, ... Proceedings of the National Academy of Sciences 105 (8), 3011-3016, 2008 | 575 | 2008 |
| Nonpeptide ligands for human gamma delta T cells. Y Tanaka, S Sano, E Nieves, G De Libero, D Rosa, RL Modlin, ... Proceedings of the National Academy of Sciences 91 (17), 8175-8179, 1994 | 516 | 1994 |
| Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues M Ishida, Y Iwai, Y Tanaka, T Okazaki, GJ Freeman, N Minato, T Honjo Immunology letters 84 (1), 57-62, 2002 | 401 | 2002 |
| V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. JF Bukowski, CT Morita, Y Tanaka, BR Bloom, MB Brenner, H Band Journal of immunology (Baltimore, Md.: 1950) 154 (3), 998-1006, 1995 | 357 | 1995 |
| TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections LW Shen, HJ Mao, YL Wu, Y Tanaka, W Zhang Biochimie 142, 1-10, 2017 | 329 | 2017 |
| Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation Y Li, T Koshiba, A Yoshizawa, Y Yonekawa, K Masuda, A Ito, M Ueda, ... American journal of transplantation 4 (12), 2118-2125, 2004 | 316 | 2004 |
| The C-kit receptor-mediated signal transduction and tumor-related diseases J Liang, YL Wu, BJ Chen, W Zhang, Y Tanaka, H Sugiyama International journal of biological sciences 9 (5), 435, 2013 | 307 | 2013 |
| Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics BJ Chen, YL Wu, Y Tanaka, W Zhang International journal of biological sciences 10 (10), 1084, 2014 | 304 | 2014 |
| Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study H Kobayashi, Y Tanaka, J Yagi, Y Osaka, H Nakazawa, T Uchiyama, ... Cancer Immunology, Immunotherapy 56, 469-476, 2007 | 302 | 2007 |
| Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma H Kobayashi, Y Tanaka, J Yagi, N Minato, K Tanabe Cancer Immunology, Immunotherapy 60, 1075-1084, 2011 | 243 | 2011 |
| Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human γδ T cells by aminobisphosphonate antigen F Miyagawa, Y Tanaka, S Yamashita, N Minato The Journal of Immunology 166 (9), 5508-5514, 2001 | 236 | 2001 |
| γδ T cells and their potential for immunotherapy YL Wu, YP Ding, Y Tanaka, LW Shen, CH Wei, N Minato, W Zhang International journal of biological sciences 10 (2), 119, 2014 | 206 | 2014 |
| Targeting of tumor cells for human γδ T cells by nonpeptide antigens Y Kato, Y Tanaka, F Miyagawa, S Yamashita, N Minato The Journal of Immunology 167 (9), 5092-5098, 2001 | 204 | 2001 |
Craig T. MoritaUniversity of IowaAdresă de e-mail confirmată pe uiowa.edu